메뉴 건너뛰기




Volumn 13, Issue 3, 2010, Pages 527-536

The 6-month persistence on SSRIs and associated economic burden

Author keywords

Antidepressants; Healthcare costs; Persistence; Reimbursement claims database; Retrospective studies; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

EID: 77956695118     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696998.2010.511050     Document Type: Article
Times cited : (25)

References (36)
  • 1
    • 38649109856 scopus 로고    scopus 로고
    • Increase in antidepressant medication in the US adult population between 1990 and 2003
    • Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008;77:83-92
    • Psychother Psychosom , vol.2008 , Issue.77 , pp. 83-92
    • Mojtabai, R.1
  • 4
    • 8344285038 scopus 로고    scopus 로고
    • Trends in service use and treatment for mental disorders in adults throughout Great Britain
    • Brugha TS, Bebbington PE, Singleton N, et al. Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry 2004;185:378-384
    • (2004) Br J Psychiatry , vol.185 , pp. 378-384
    • Brugha, T.S.1    Bebbington, P.E.2    Singleton, N.3
  • 5
    • 0038137620 scopus 로고    scopus 로고
    • Association between antidepressant prescribing and suicide in Australia, 1991-2000: Trend analysis
    • Hall WD, Mant A, Mitchell PB, et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ 2003;326:1008
    • (2003) BMJ , vol.326 , pp. 1008
    • Hall, W.D.1    Mant, A.2    Mitchell, P.B.3
  • 7
    • 1242338645 scopus 로고    scopus 로고
    • The economic burden of depression in the United States: How did it change between 1990 and 2000?
    • Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-1475
    • J Clin Psychiatry , vol.2003 , Issue.64 , pp. 1465-1475
    • Greenberg, P.E.1    Kessler, R.C.2    Birnbaum, H.G.3
  • 8
    • 0344348817 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database
    • Isacsson G, Boethius G, Henriksson S, et al. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord 1999;53:15-22
    • (1999) J Affect Disord , vol.53 , pp. 15-22
    • Isacsson, G.1    Boethius, G.2    Henriksson, S.3
  • 9
    • 77952469875 scopus 로고    scopus 로고
    • Prescription patterns of antidepressants: Findings from a US claims database
    • Milea D, Verpillat P, Guelfucci F, et al. Prescription patterns of antidepressants: findings from a US claims database. Curr Med Res Opin 2010;26: 1343-1353
    • (2010) Curr Med Res Opin , vol.26 , pp. 1343-1353
    • Milea, D.1    Verpillat, P.2    Guelfucci, F.3
  • 10
    • 2342606503 scopus 로고    scopus 로고
    • Economic implications of treatment-resistant depression among employees
    • Greenberg P, Corey-Lisle PK, Birnbaum H, et al. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics 2004;22:363-373
    • (2004) Pharmacoeconomics , vol.22 , pp. 363-373
    • Greenberg, P.1    Corey-Lisle, P.K.2    Birnbaum, H.3
  • 11
    • 0034612163 scopus 로고    scopus 로고
    • Recovery from depression, work productivity, and health care costs among primary care patients
    • Simon GE, Revicki D, Heiligenstein J, et al. Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry 2000;22:153-162
    • (2000) Gen Hosp Psychiatry , vol.22 , pp. 153-162
    • Simon, G.E.1    Revicki, D.2    Heiligenstein, J.3
  • 12
    • 0033989126 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with major depressive disorder revision
    • American Psychiatric Association
    • Practice guideline for the treatment of patients with major depressive disorder revision. American Psychiatric Association. Am J Psychiatry 2000;157:1-45
    • (2000) Am J Psychiatry , vol.157 , pp. 1-45
  • 13
    • 77956708733 scopus 로고    scopus 로고
    • NICE (National Institute for Health and Clinical Excellence)
    • National Clinical Practice Guideline Number 23 amended.
    • NICE (National Institute for Health and Clinical Excellence). Depression: Management of depression in primary and secondary care. National Clinical Practice Guideline Number 23 amended. 2007
    • (2007) Depression: Management of Depression in Primary and Secondary Care
  • 14
    • 33645283080 scopus 로고    scopus 로고
    • Analysing duration of episodes of pharmacological care: An example of antidepressant use in Danish general practice
    • Gichangi A, Andersen M, Kragstrup J, et al.Analysing duration of episodes of pharmacological care: an example of antidepressant use in Danish general practice. Pharmacoepidemiol Drug Saf 2006;15:167-177
    • (2006) Pharmacoepidemiol Drug Saf , vol.15 , pp. 167-177
    • Gichangi, A.1    Andersen, M.2    Kragstrup, J.3
  • 15
    • 0036757726 scopus 로고    scopus 로고
    • Antidepressants consumption in the global population in France
    • Olie JP, Elomari F, Spadone C, et al. Antidepressants consumption in the global population in France. Encephale 2002;28:411-417
    • (2002) Encephale , vol.28 , pp. 411-417
    • Olie, J.P.1    Elomari, F.2    Spadone, C.3
  • 16
    • 0034754321 scopus 로고    scopus 로고
    • Antidepressant drug prescribing in Italy, 2000: Analysis of a general practice database
    • Pietraru C, Barbui C, Poggio L, et al. Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database. Eur J Clin Pharmacol 2001; 57:605-609
    • (2001) Eur J Clin Pharmacol , vol.57 , pp. 605-609
    • Pietraru, C.1    Barbui, C.2    Poggio, L.3
  • 17
    • 53549130993 scopus 로고    scopus 로고
    • Differences in medication adherence and healthcare resource utilization patterns: Older versus newer antidepressant agents in patients with depression and/or anxiety disorders
    • Sheehan DV, Keene MS, Eaddy M, et al. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders. CNS Drugs 2008;22:963-973
    • (2008) CNS Drugs , vol.22 , pp. 963-973
    • Sheehan, D.V.1    Keene, M.S.2    Eaddy, M.3
  • 18
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence: Terminology and definitions
    • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-47
    • (2008) Value Health , vol.11 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 19
    • 33846468943 scopus 로고    scopus 로고
    • A checklist for medication compliance and persistence studies using retrospective databases
    • Peterson AM, Nau DP, Cramer JA, et al.A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007; 10:3-12
    • (2007) Value Health , vol.10 , pp. 3-12
    • Peterson, A.M.1    Nau, D.P.2    Cramer, J.A.3
  • 20
    • 47949124494 scopus 로고    scopus 로고
    • Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: A US managed care study
    • Foody JM, Joyce AT, Rudolph AE, et al. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. Curr Med Res Opin 2008;24:1987-2000
    • (2008) Curr Med Res Opin , vol.24 , pp. 1987-2000
    • Foody, J.M.1    Joyce, A.T.2    Rudolph, A.E.3
  • 21
    • 37149049314 scopus 로고    scopus 로고
    • Continuation and maintenance use of antidepressants in recurrent depression
    • Bockting CL, ten Doesschate MC, Spijker J, et al. Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom 2008;77:17-26
    • (2008) Psychother Psychosom , vol.77 , pp. 17-26
    • Bockting, C.L.1    Ten Doesschate, M.C.2    Spijker, J.3
  • 23
    • 38449102571 scopus 로고    scopus 로고
    • Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression
    • Trivedi MH, Lin EH, Katon WJ. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. CNS Spectr 2007;12:1-27
    • (2007) CNS Spectr , vol.12 , pp. 1-27
    • Trivedi, M.H.1    Lin, E.H.2    Katon, W.J.3
  • 24
    • 64849100165 scopus 로고    scopus 로고
    • Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States
    • Esposito D, Wahl P, Daniel G, et al. Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clin Ther 2009;31:644-656
    • (2009) Clin Ther , vol.31 , pp. 644-656
    • Esposito, D.1    Wahl, P.2    Daniel, G.3
  • 25
    • 37349059292 scopus 로고    scopus 로고
    • Six-month compliance with antidepressant medication in the treatment of major depressive disorder
    • Demyttenaere K, Adelin A, Patrick M, et al. Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int Clin Psychopharmacol 2008;23:36-42
    • (2008) Int Clin Psychopharmacol , vol.23 , pp. 36-42
    • Demyttenaere, K.1    Adelin, A.2    Patrick, M.3
  • 26
    • 62649159932 scopus 로고    scopus 로고
    • Adherence to continuation and maintenance antidepressant use in recurrent depression
    • ten Doesschate MC, Bockting CL, Schene AH. Adherence to continuation and maintenance antidepressant use in recurrent depression. J Affect Disord 2009;115:167-170
    • (2009) J Affect Disord , vol.115 , pp. 167-170
    • Ten Doesschate, M.C.1    Bockting, C.L.2    Schene, A.H.3
  • 27
    • 33748987671 scopus 로고    scopus 로고
    • Remission, dropouts, and adverse drug reaction rates in major depressive disorder: A meta-analysis of head-to-head trials
    • Machado M, Iskedjian M, Ruiz I, et al. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Curr Med Res Opin 2006;22:1825-1837
    • (2006) Curr Med Res Opin , vol.22 , pp. 1825-1837
    • MacHado, M.1    Iskedjian, M.2    Ruiz, I.3
  • 28
    • 33746118434 scopus 로고    scopus 로고
    • A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
    • Boulenger JP, Huusom AK, Florea I, et al. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Curr Med Res Opin 2006;22:1331-1341
    • (2006) Curr Med Res Opin , vol.22 , pp. 1331-1341
    • Boulenger, J.P.1    Huusom, A.K.2    Florea, I.3
  • 29
    • 33645787677 scopus 로고    scopus 로고
    • Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: A meta-analysis
    • Kennedy SH, Andersen HF, Lam RW. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. J Psychiatry Neurosci 2006;31:122-131
    • (2006) J Psychiatry Neurosci , vol.31 , pp. 122-131
    • Kennedy, S.H.1    Andersen, H.F.2    Lam, R.W.3
  • 30
    • 33748551702 scopus 로고    scopus 로고
    • The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: An extended analysis
    • Lam RW, Andersen HF. The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis. Pharmacopsychiatry 2006;39:180-184
    • (2006) Pharmacopsychiatry , vol.39 , pp. 180-184
    • Lam, R.W.1    Andersen, H.F.2
  • 31
    • 14844365616 scopus 로고    scopus 로고
    • Efficacy of escitalopram in patients with severe depression: A pooled analysis
    • Llorca PM, Azorin JM, Despiegel N, et al. Efficacy of escitalopram in patients with severe depression: a pooled analysis. Int J Clin Pract 2005; 59:268-275
    • (2005) Int J Clin Pract , vol.59 , pp. 268-275
    • Llorca, P.M.1    Azorin, J.M.2    Despiegel, N.3
  • 32
    • 34948908624 scopus 로고    scopus 로고
    • Which antidepressants have demonstrated superior efficacy? A review of the evidence
    • Montgomery SA, Baldwin DS, Blier P, et al. Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 2007;22:323-329
    • (2007) Int Clin Psychopharmacol , vol.22 , pp. 323-329
    • Montgomery, S.A.1    Baldwin, D.S.2    Blier, P.3
  • 33
    • 17644423099 scopus 로고    scopus 로고
    • Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
    • Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005;20:131-137
    • (2005) Int Clin Psychopharmacol , vol.20 , pp. 131-137
    • Moore, N.1    Verdoux, H.2    Fantino, B.3
  • 34
    • 62749199746 scopus 로고    scopus 로고
    • Economic impact of non-persistence antidepressant therapy in the Quebec community-dwelling elderly population
    • Tournier M, Moride Y, Crott R, et al. Economic impact of non-persistence antidepressant therapy in the Quebec community-dwelling elderly populatio J Affect Disord 2009;115:160-166
    • (2009) J Affect Disord , vol.115 , pp. 160-166
    • Tournier, M.1    Moride, Y.2    Crott, R.3
  • 35
    • 55549097838 scopus 로고    scopus 로고
    • Comparison of treatment persistenc hospital utilization and costs among major depressive disorder geriatr patients treated with escitalopram versus other SSRI/SNRI antidepressant
    • Wu E, Greenberg P, Yang E, et al. Comparison of treatment persistenc hospital utilization and costs among major depressive disorder geriatr patients treated with escitalopram versus other SSRI/SNRI antidepressant Curr Med Res Opin 2008;24:2805-2813
    • (2008) Curr Med Res Opin , vol.24 , pp. 2805-2813
    • Wu, E.1    Greenberg, P.2    Yang, E.3
  • 36
    • 53349173864 scopus 로고    scopus 로고
    • Comparison of escitalopram versi citalopram for the treatment of major depressive disorder in a geriatric
    • Wu E, Greenberg PE, Yang E, et al. Comparison of escitalopram versi citalopram for the treatment of major depressive disorder in a geriatric population. Curr Med Res Opin 2008;24:2587-2595
    • (2008) Population. Curr Med Res Opin , vol.24 , pp. 2587-2595
    • Wu, E.1    Greenberg, P.E.2    Yang, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.